β-Lapachone
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


β-Lapachone
Description :
β-Lapachone (ARQ-501; NSC-26326) is a naturally occurring O-naphthoquinone, acts as a topoisomerase I inhibitor, and induces apoptosis by inhibiting cell cycle progression.Product Name Alternative :
ARQ-501; NSC-26326UNSPSC :
12352005Hazard Statement :
H302, H315, H319, H335Target :
Apoptosis; Autophagy; Indoleamine 2,3-Dioxygenase (IDO) ; TopoisomeraseType :
Natural ProductsRelated Pathways :
Apoptosis; Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/ProteaseApplications :
Cancer-programmed cell deathField of Research :
CancerAssay Protocol :
https://www.medchemexpress.com/_beta_-Lapachone.htmlPurity :
99.96Solubility :
DMSO : 25 mg/mL (ultrasonic) |Ethanol : 8.33 mg/mL (ultrasonic)Smiles :
O=C(C1=C2OC(C)(C)CC1)C(C3=C2C=CC=C3)=OMolecular Formula :
C15H14O3Molecular Weight :
242.27Precautions :
H302, H315, H319, H335References & Citations :
[1]Li CJ, et al. beta-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin. J Biol Chem. 1993 Oct 25;268 (30) :22463-8.|[2]Vanni A, et al. DNA damage and cytotoxicity induced by beta-lapachone: relation to poly (ADP-ribose) polymerase inhibition. Mutat Res. 1998 Jun 5;401 (1-2) :55-63.|[3]Kim TW, et al. β-Lapachone enhances Mre11-Rad50-Nbs1 complex expression in cisplatin-induced nephrotoxicity. Pharmacol Rep. 2016 Feb;68 (1) :27-31.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Natural ProductsClinical Information :
Phase 2Isoform :
Topo ICAS Number :
[4707-32-8]

